Group 1 - The company Harsan (002900) announced that its director, vice president, and board secretary Liang Yanfei plans to reduce his holdings by no more than 202,200 shares, accounting for 0.0639% of the total share capital [1] - Director Zhu Zihong plans to reduce his holdings by no more than 25,000 shares, representing 0.0079% of the total share capital [1] - Chief Financial Officer Zhao Zhicheng also plans to reduce his holdings by no more than 25,000 shares, which is 0.0079% of the total share capital [1] Group 2 - The reason for the share reduction is personal financial needs [1] - The method of reduction will be through centralized bidding transactions [1] - The reduction period is set for three months starting from 15 trading days after the announcement date [1]

证券代码：002900 证券简称：哈三联 公告编号：2025-033 哈尔滨三联药业股份有限公司 关于董事、高级管理人员减持股份的预披露公告 董事、副总裁、董事会秘书梁延飞先生，董事朱自红先生、财务总监赵志成 先生保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、持有哈尔滨三联药业股份有限公司（以下简称"公司"或"本公司"）股份 808,800股（占本公司总股本比例0.2557%）的董事、副总裁、董事会秘书梁延飞 先生计划在自本减持计划公告之日起15个交易日后的3个月内（即2025年7月7日 -2025年10月6日，且窗口期不减持），以集中竞价方式减持本公司股份不超过 202,200股（占本公司总股本比例0.0639%）。 2、持有本公司股份100,000股（占本公司总股本比例0.0316%）的董事朱自 红先生计划在自本减持计划公告之日起15个交易日后的3个月内（即2025年7月7 日-2025年10月6日，且窗口期不减持），以集中竞价方式减持本公司股份不超过 25,000股（占本公司总股本比 ...

Group 1 - The A-share chemical pharmaceutical sector is experiencing a volatile correction, with companies such as Haichen Pharmaceutical and Yong'an Pharmaceutical both declining over 9% [1] - Other companies including Yipinhong, Hasanlian, Tonghua Jinma, Hanyu Pharmaceutical, and Hehua Co. have also seen declines of around 5% [1]

Summary of Key Points Core Viewpoint - A total of 900 stocks reported their latest shareholder numbers as of May 31, with 396 stocks showing a decline compared to the previous period, indicating a trend of decreasing shareholder engagement in certain companies [1][3]. Group 1: Shareholder Changes - Among the 900 stocks, 29 stocks experienced a decline in shareholder numbers exceeding 10% [3]. - The stock with the largest decline in shareholder numbers was Ha Sanlian, which saw a decrease of 25.74% to 40,260 shareholders [3]. - Zhongxin Fluorine Materials followed with a 23.76% decrease in shareholder numbers, totaling 47,067 [3]. Group 2: Stock Performance - The average increase for concentrated stocks since May 11 was 4.30%, outperforming the Shanghai Composite Index, which rose by 1.28% [2]. - Among the stocks with a decline in shareholder numbers, *ST and Ke achieved the highest increase of 36.06% since May 11 [2]. - Stocks such as Gongchuang Lawn, Tainkang, and Taotao Automotive saw significant increases of 92.94%, 59.73%, and 40.03%, respectively, since the last monitoring period [3]. Group 3: Industry Concentration - The concentrated stocks were primarily found in the machinery, basic chemicals, and electronics sectors, with 47, 39, and 39 stocks respectively [3].

Market Overview - The Shanghai Composite Index closed at 3384.82 points, below the five-day moving average, with a decline of 0.44% [1] - The total trading volume of A-shares reached 14,514.37 million yuan [1] Stocks Performance - A total of 219 A-shares broke through the five-day moving average today [1] - Stocks with significant deviation rates include: - Huaguang Yuanhai with a deviation rate of 20.27% and a daily increase of 26.88% [1] - Shuguang Shuchuang with a deviation rate of 15.32% and a daily increase of 24.01% [1] - Haooubo with a deviation rate of 12.92% and a daily increase of 20.00% [1] - Stocks with smaller deviation rates that just crossed the five-day moving average include: - Dongfang Precision, Zijin Bank, and Chuanheng Co., with minor deviation rates [1]

Market Overview - The Shanghai Composite Index closed at 3403.52 points, above the five-day moving average, with a slight increase of 0.11% [1] - The total trading volume of A-shares reached 808.39 billion yuan [1] Stocks Performance - A total of 253 A-shares have surpassed the five-day moving average today [1] - Notable stocks with significant deviation rates include: - Shuguang Digital (14.08% deviation) - Sun Cable (8.01% deviation) - Suqian Liansheng (7.42% deviation) [1] Top Gainers - The top gainers today include: - Shuguang Digital: 22.27% increase, latest price at 61.87 yuan - Sun Cable: 10.00% increase, latest price at 6.82 yuan - Suqian Liansheng: 10.00% increase, latest price at 9.90 yuan [1] Additional Notable Stocks - Other stocks with notable performance: - Celery Medical: 9.97% increase, latest price at 13.46 yuan - Zhongke Shuguang: 10.00% increase, latest price at 68.09 yuan - Yuanwang Valley: 9.97% increase, latest price at 7.28 yuan [1]

哈尔滨三联药业股份有限公司 2、公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较 大影响的未公开重大信息； 3、公司近期经营情况正常，内外部经营环境未发生重大变化； 证券代码：002900 证券简称：哈三联 公告编号：2025-032 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 哈尔滨三联药业股份有限公司（以下简称"公司"或"本公司"）（证券代码： 002900，证券简称：哈三联）股票连续 2 个交易日内（2025 年 5 月 30 日、2025 年 6 月 3 日）日收盘价格涨幅偏离值累计超过 20%，根据《深圳证券交易所交易 规则》的相关规定，属于股票交易异常波动情况。 二、公司关注并核实情况的说明 针对公司股票交易的异常波动，公司董事会对公司、控股股东及实际控制人 就相关事项进行了核实，现就有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处； 四、风险提示 1、经自查，公司不存在违反信息公平披露的情形。 2、公司郑重提醒广大投资者：《证券时报》、《中国证券报》、《上海 ...

哈尔滨三联药业股份有限公司关于公司 控股股东、实际控制人部分股份解除质押及再质押的公告 证券代码：002900 证券简称：哈三联 公告编号：2025-031 4、股东股份累计被质押的情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 哈尔滨三联药业股份有限公司（以下简称"公司"）于近日接到公司控股股东、 实际控制人秦剑飞先生的通知，获悉秦剑飞先生部分股份办理解除质押及再质押， 具体事项如下： 一、控股股东、实际控制人部分股份质押的基本情况 | 股东名 称 | 是否第一大 股东及其一 致行动人 | 本次解除质押 股份数量（股） | 占其所持股 份比例 | 占公司总 股本比例 | 质押起始日 | 解除日期 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | 秦剑飞 | 是 | 25,000,000 | 20.21% | 7.90% | 2022-06-06 | 2025-05-30 | 国泰海通 | | | | 9,000,000 | 7.28% | 2.84% | 2023-06-06 | 2 ...

今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 猪肉 | 2.39 | 可控核聚变 | -3.47 | | 养鸡 | 1.94 | 减速器 | -3.18 | | 创新药 | 1.56 | EDR概念 | -3.01 | | 动物疫苗 | 1.35 | 人形机器人 | -2.90 | | 眼科医疗 | 1.30 | 一体化压铸 | -2.79 | | 细胞免疫治疗 | 1.25 | 汽车热管理 | -2.63 | | 青蒿素 | 1.17 | 无线充电 | -2.51 | | 仿制药一致性评价 | 1.16 | 铜缆高速连接 | -2.49 | | 重组蛋白 | 1.11 | 拼多多概念 | -2.48 | | 生物疫苗 | 1.01 | 智能座舱 | -2.48 | 资金面上看，今日仿制药一致性评价概念板块获主力资金净流入4.35亿元，其中，63股获主力资金净流 入，6股主力资金净流入超5000万元，净流入资金居首的是千红制药，今日主力资金净流入2.20亿元， 净流入资金居前的还有海南海药、哈三联、鲁抗医药 ...

一、行情回顾 市场全天震荡调整，创业板指领跌。创新药概念逆势大涨，睿智医药、海南海药、哈三联等多股涨停。猪肉、鸡肉股拉升，巨星农牧、湘佳股份封板。银行 股继续走强，杭州银行、成都银行创历史新高。下跌方面，高位股集体大跌，王子新材等多股跌停。个股跌多涨少，沪深京三市超4100股飘绿，今日成交 1.16万亿。 根据渤海证券统计，本周多款创新药获批上市，包括恒瑞医药的瑞康曲妥珠单抗、磷罗拉匹坦帕洛诺司琼、苹果酸法米替尼，复星医药的枸橼酸伏维西利、 芦沃美替尼，百济神州的泽尼达妥单抗，泽璟制药的盐酸吉卡昔替尼等，同时美国关税政策边际变化带动 CXO 板块快速反弹。 2025年美国临床肿瘤学会（ASCO）即将于当地时间5月30日至6月3日在美国芝加哥召开。 | 股票名称 | | 最新价 = | 涨跌幅 = | 涨停时间 = | 换手率 = | 流通市值 = | | | --- | --- | --- | --- | --- | --- | --- | --- | | 华森制药 | 4天4板 | 20.63 | +10.03% | 09:32:48 | 4.42% | 63.72亿 | 公司旗下5个产品完 美拉唑碳酸氢钠 ...